DT
HealthMore in Health→
Psilocybin is moving deeper into depression research, but the evidence still comes with limits
Key Takeaways
- Researchers reviewed 15 clinical trials testing psilocybin for depression.
- The analysis was published in Nature Mental Health.
- The review strengthens the case for continued study while emphasizing methodological limits.
- Interest is being driven in part by patients who do not benefit enough from standard treatments.
DE
DT Editorial Team··via medicalxpress.com
